| # | Drug | Count |
|---|---|---|
| 0 | ALTEPLASE | 197 |
| 1 | PREDNISONE | 146 |
| 2 | DEXAMETHASONE | 133 |
| 3 | DEXAMETHASONE 1.5 MG | 133 |
| 4 | LEVETIRACETAM | 124 |
| 5 | METHOTREXATE SODIUM | 120 |
| 6 | RITUXIMAB | 118 |
| 7 | CYCLOPHOSPHAMIDE | 114 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 114 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 114 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OCTOPAMINE | 1 | 1.0000 |
| 1 | TENECTEPLASE | 29 | 0.0181 |
| 2 | MIGLUSTAT | 19 | 0.0162 |
| 3 | ACAMPROSATE CALCIUM | 5 | 0.0150 |
| 4 | DEMECLOCYCLINE | 3 | 0.0132 |
| 5 | ALTEPLASE | 197 | 0.0131 |
| 6 | FLUMAZENIL | 11 | 0.0124 |
| 7 | CLORAZEPATE DIPOTASSIUM | 21 | 0.0107 |
| 8 | PROBENECID AND COLCHICINE | 1 | 0.0098 |
| 9 | PENICILLAMINE | 8 | 0.0086 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 393 |
| 1 | Benzodiazepine [EPC] | 221 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 207 |
| 3 | Alkylating Drug [EPC] | 181 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 138 |
| 5 | Atypical Antipsychotic [EPC] | 136 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 127 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 117 |
| 8 | Mood Stabilizer [EPC] | 110 |
| 9 | Opioid Agonist [EPC] | 109 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 19 | 0.0162 |
| 1 | Benzodiazepine Antagonist [EPC] | 11 | 0.0124 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 19 | 0.0067 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 6 | 0.0042 |
| 4 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 5 | CD33-directed Immunoconjugate [EPC] | 10 | 0.0027 |
| 6 | Osmotic Diuretic [EPC] | 13 | 0.0025 |
| 7 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 27 | 0.0021 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 15 | 0.0019 |